GILLIS JONATHAN (CAAO and PAO) sold 20.4% of their position (36.98K shares) of MAPLIGHT THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.37M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Voting Common Stock
Shares
−5.36K
Price / share
$36.13
Trade value
$193.51K
% of position
Voting Common Stock
Shares
−4.70K
Price / share
$36.94
Trade value
$173.58K
% of position
Voting Common Stock
Shares
−6.98K
Price / share
$36.66
Trade value
$255.85K
% of position
Voting Common Stock
Shares
−1.48K
Price / share
$37.44
Trade value
$55.26K
% of position
Voting Common Stock
Shares
−600.00
Price / share
$36.51
Trade value
$21.91K
% of position
Voting Common Stock
Shares
−16.97K
Price / share
$37.61
Trade value
$638.20K
% of position
Voting Common Stock
Shares
−900.00
Price / share
$38.17
Trade value
$34.35K
% of position
Net shares
−36.98K
Net value
-$1.37M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Voting Common Stock Direct | 7/15/2026 | S · Sale | −5.36K | $36.13 | $193.51K | 3.0% | 181.22K | 175.86K |
| Voting Common Stock Direct | 7/15/2026 | S · Sale | −4.70K | $36.94 | $173.58K | 2.7% | 175.86K | 171.16K |
| Voting Common Stock Direct | 7/16/2026 | S · Sale | −6.98K | $36.66 | $255.85K | 4.1% | 171.16K | 164.19K |
| Voting Common Stock Direct | 7/16/2026 | S · Sale | −1.48K | $37.44 | $55.26K | 0.9% | 164.19K | 162.71K |
| Voting Common Stock Direct | 7/17/2026 | S · Sale | −600.00 | $36.51 | $21.91K | 0.4% | 162.71K | 162.11K |
| Voting Common Stock Direct | 7/17/2026 | S · Sale | −16.97K | $37.61 | $638.20K | 10.5% | 162.11K | 145.14K |
| Voting Common Stock Direct | 7/17/2026 | S · Sale | −900.00 | $38.17 | $34.35K | 0.6% | 145.14K | 144.24K |
| Total | −36.98K | -$1.37M | ||||||